Acrivon Therapeutics' Seed Round

Acrivon Therapeutics raised a round of funding on May 07, 2018.

Acrivon Therapeutics is a biotech company specializing in drug development through early clinical treatment success using our unique predictive biomarker approach.…

Articles about Acrivon Therapeutics' Seed Round: